Whole-genome sequencing and the physician

Clinical Genetics

Volumn 81, Issue 6, 2012, Pages 511-513

  Thorogood, A ^a   Knoppers, B M ^a   Dondorp, W J ^b   de Wert, G M W R ^b  

^a MCGILL UNIVERSITY   (Canada)

^b MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

FOLLOW UP; GENE SEQUENCE; GENETIC SCREENING; HUMAN; INFORMED CONSENT; MEDICAL ETHICS; NOTE; PRIORITY JOURNAL; PROFESSIONAL SECRECY; WHOLE GENOME SEQUENCING;

CHROMOSOME MAPPING; CONFIDENTIALITY; DUTY TO RECONTACT; ETHICS, CLINICAL; GENETIC TESTING; GENOME, HUMAN; HUMANS; INFORMED CONSENT; PHYSICIAN'S ROLE; SEQUENCE ANALYSIS, DNA;

EID: 84860584490     PISSN: 00099163     EISSN: 13990004     Source Type: Journal    
DOI: 10.1111/j.1399-0004.2012.01868.x     Document Type: Note

References (33)

1. Foundation for Genomics and Population Health, Next steps in the sequence, the implications of whole genome sequencing for health in the UK. Cambridge, MA: PHG Foundation, 2011.
2. Feero WG, Guttmacher AE, Collins FS. Genomic medicine - an updated primer. N Engl J Med 2010: 362 (21): 2001-2011.
3. Poot M, Hochstenbach R. A three-step work flow procedure for the interpretation of array-based comparative genome hybridization results in patients with idiopathic mental retardation and congenital anomalies. Genet Med 2010: 12 (8): 478-485.
4. Tucker T, Marra M, Friedman JM. Massively parallel sequencing: the next big thing in genetic medicine. Am J Hum Genet 2009: 85 (2): 142-154.
5. Burke W, Tarini B, Press NA, Evans JP. Genetic screening. Epidemiol Rev 2011: 33 (1): 148-164.
6. Dondorp WJ, de Wert GM. The 'thousand-dollar genome': an ethical exploration, Monitoring Report Ethics and Health, 2010/2. The Hague: Centre for Ethics and Health, 2010.
7. Worthey EA, Mayer AN, Syverson GD et al. Making a definitive diagnosis: successful clinical application of whole exome sequencing in a child with intractable inflammatory bowel disease. Genet Med 2011: 13: 255-262.
8. Mayer AN, Dimmock DP, Arca MJ et al. A timely arrival for genomic medicine. Genet Med 2011: 13 (3): 195-196.
9. World Medical Association. Medical ethics manual, Ferney-Voltaire Cedex. France: World Medical Association, 2009.
10. Canadian Medical Association. Code of ethics, update. Ottawa, Canada: Canadian Medical Association, 2004.
11. Knoppers BM, Lévesque E. Return of research results: how should research results be handled? J Law Med Ethics 2011: 39 (4): 574-639.
12. Canadian Institutes of Health Research (CIHR), Natural Sciences and Engineering Research Council of Canada, Social Sciences and Humanities Research Council of Canada, Tri-Council Policy Statement. Ottawa, Canada: Ethical Conduct for Research Involving Humans, 2010.
13. Wallace S, Lazor S, Knoppers BM. Consent and population genomics: the creation of generic tools. IRB 2009: 31 (2): 15-20.
14. National Cancer Institute. Workshop Summary: Workshop on the Release of Research Results to Participants in Biospecimen Studies, Bethesda, MD, 8-9 July 2010.
15. Berg JS, Khoury MJ, Evans JP. Deploying whole genome sequencing in clinical practice and public health: meeting the challenge one bin at a time. Genet Med 2011: 13 (6): 499-504.
16. Bunnik E, Schermer M, Janssens AC. Personal genome testing: test characteristics to clarify the discourse on ethical, legal and societal issues. BMC Med Ethics 2011: 12 (11): 1-13.
17. American Medical Association. Code of ethics. Chicago, IL: American Medical Association, 20102011.
18. Downie J, Caulfield T, Flood C. Canadian health law and policy, 3rd edn. Markham: LexisNexis, 2007.
19. Phillips v United States, 566 F Suppl 1 (1981).
20. Marchant GE, Campos-Outcalt DE, Lindor RA. Physician liability: the next big thing for personalized medicine? Pers Med 2011: 8 (4): 457.
21. Kohane IS, Masys DR, Altman RB. The incidentalome: a threat to genomic medicine. JAMA 2006: 296 (2): 212-215.
22. Grosse SD, Khoury MJ. What is the clinical utility of genetic testing? Genet Med 2006: 8 (7): 448-450.
23. Kuehn BM. Scientists see promise and challenges in translating genomics to the clinic. JAMA 2011: 305 (13): 1285-1286.
24. McGuire AL. An unwelcome side effect of direct-to-consumer personal genome testing. JAMA 2008: 300 (22): 2669-2671.
25. Pyeritz RE. The coming explosion in genetic testing - is there a duty to recontact? N Engl J Med 2011: 365: 1367-1369.
26. Knoppers BM. Duty to recontact: a legal harbinger? Am J Med Genet 2001: 103 (4): 277.
27. Hunter AGW, Sharpe N, Mullen M, Meschino WS. Ethical, legal, and practical concerns about recontacting patients to inform them of new information: the case in medical genetics. Am J Med Genet 2001: 103: 265-276.
28. Flanagan WF. Genetic data and medical confidentiality. Health Law J 1995: 3: 269-288.
29. Watters v White, Quebec Court of Appeal QCCA 257 (2012).
30. American Society of Human Genetics. ASHG statement: professional disclosure of familial genetic information. Am J Hum Genet 1998: 62: 474-483.
31. Lacroix M, Nycum G, Godard B, Knoppers BM. Should physicians warn patients' relatives of genetic risks? CMAJ 2008: 178 (5): 593-595.
32. Safer v Estate of Pack, 677 A 2d, NJ Super Ct App Div (1996).
33. Andorno R. The right not to know: an autonomy based approach. J Med Ethics 2004: 30: 435-439.